![Jean-Marie Houle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jean-Marie Houle worked as Vice President-Research & Development at Chronogen, Inc. from 2006 to 2010.
Prior to that, he worked as a Principal at LAB Pharmacological Research International.
He received a graduate and doctorate degree from the University of Montréal.
Ehemalige bekannte Positionen von Jean-Marie Houle
Unternehmen | Position | Ende |
---|---|---|
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Technik-/Wissenschafts-/F&E-Leiter | 23.04.2010 |
LAB Pharmacological Research International | Corporate Officer/Principal | - |
Ausbildung von Jean-Marie Houle
University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Health Technology |
LAB Pharmacological Research International |